Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 08.06.2026 1 Acta Neuropathol 3 Alzheimer Dis Assoc Disord 7 Alzheimers Dement 1 BMC Neurol 1 Brain 1 Brain Res 2 Curr Alzheimer Res 1 Dement Geriatr Cogn Disord 1 Int J Neurosci 16 J Alzheimers Dis 1 J Neurol 1 Neurochem Res 2 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. DUNOT J, Gandin C, Truchi M, Pirro G, et al
   AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.
   Acta Neuropathol. 2026;151:65.
   PubMed         Abstract available
   
   

   
   Alzheimer Dis Assoc Disord

2. TOTUK O
   CHMP2B p.Ala30Ser Variant in Biomarker-Confirmed Early-Onset Alzheimer Disease: A Potential Endolysosomal Disease Modifier.
   Alzheimer Dis Assoc Disord. 2026 Jun 4. doi: 10.1097/WAD.0000000000000737.
   PubMed         Abstract available
   
   
3. BRANDT E, Koivisto A, Pereira P, Mustanoja E, et al
   Early Gut Microbiome Alterations in Mild Cognitive Impairment Reflect Changes in Alzheimer Disease.
   Alzheimer Dis Assoc Disord. 2026 Jun 3. doi: 10.1097/WAD.0000000000000732.
   PubMed         Abstract available
   
   
4. SU Y, Ren H, Huang S, Hao Y, et al
   Identification of Functional lncRNAs in Alzheimer Disease by Integrative Analysis of lncRNA-mRNA Network Based on Competing Endogenous RNA Mechanism.
   Alzheimer Dis Assoc Disord. 2026 Jun 1. doi: 10.1097/WAD.0000000000000724.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

5. TSUDA Y, Madokoro Y, Suzuki K, Ooba T, et al
   Reduction in hippocampal cholinergic neurostimulating peptide enhances memory impairment in App(NL-G-F) KI mice.
   Alzheimers Dement. 2026;22:e71531.
   PubMed         Abstract available
   
   
6. SHIHADEH L, Rosselli M, Conniff J, Asken B, et al
   Associations among sleep quality, cognitive decline, and Alzheimer's disease pathology in older adults: A longitudinal study.
   Alzheimers Dement. 2026;22:e71470.
   PubMed         Abstract available
   
   
7. EBERLY SG, Phumsatitpong C, Munro CE, Neylan TC, et al
   Stress, stress systems, and Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71542.
   PubMed         Abstract available
   
   
8. SENADOR J, Montesinos R, Custodio B, Huilca J, et al
   Validity of the two different scoring methods of the Clinical Dementia Rating scale in staging and detection of cognitive impairment in the Peruvian population.
   Alzheimers Dement. 2026;22:e71550.
   PubMed         Abstract available
   
   
9. PALATSIDES EL, Yiallourou S, Himali D, Cavuoto MG, et al
   Influence of an AQP4 haplotype and sleep duration on early Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71540.
   PubMed         Abstract available
   
   
10. PORTER T, Armstrong AM, O'Brien EK, Dore V, et al
    Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypes.
    Alzheimers Dement. 2026;22:e71516.
    PubMed         Abstract available
    
    
11. CHAMPETIER P, Albero C, Raposo Pereira F, Herzog R, et al
    Sleep-like slow waves during resting-state: A promising EEG biomarker of amyloid and neurodegeneration in preclinical Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71514.
    PubMed         Abstract available
    
    

    
    BMC Neurol

12. EFE JJ, Anibor E, Pandey P, Sunday OG, et al
    Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies.
    BMC Neurol. 2026 Jun 5. doi: 10.1186/s12883-026-05046.
    PubMed         Abstract available
    
    

    
    Brain

13. BHARDWAJ A, Benveniste H
    Amyloid-beta-laden CSF turns guardian macrophages into collateral damage in Alzheimer's disease.
    Brain. 2026 Jun 5:awag197. doi: 10.1093.
    PubMed        
    
    

    
    Brain Res

14. LIU Y, Li L, Pu J, Xiong Y, et al
    Early and sustained Intervention with YKB Modulates the Cerebro-Retinal-Synaptic Network to Ameliorate Memory Deficits in Alzheimer's Disease.
    Brain Res. 2026 May 30:150396. doi: 10.1016/j.brainres.2026.150396.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

15. SRIDHAR SK, Goudanavar P, Naveen NR
    Mitochondrial Dysfunction in Alzheimer's Disease: Beyond Energy Failure Toward a Pathogenic Nexus.
    Curr Alzheimer Res. 2026 May 22. doi: 10.2174/0115672050433653251208201102.
    PubMed         Abstract available
    
    
16. CHELLAMMAL HSJ, Janakiraman AK, Ramachandran D, Chellappan RD, et al
    Immunotherapeutic Advances in Alzheimer's Disease: The Convergence of Vaccinology and Nanoscience.
    Curr Alzheimer Res. 2026 May 22. doi: 10.2174/0115672050415433251106050120.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

17. DELGADO F, Yu F, Peterson DS, Ofori E, et al
    Apolipoprotein E, Executive Function, and Falls across Cognitive Status: A Cross-Sectional Study.
    Dement Geriatr Cogn Disord. 2026;55:187-196.
    PubMed         Abstract available
    
    

    
    Int J Neurosci

18. G D, K P, S R, Vijaya Lakshmi TR, et al
    Bobcat-Optimized Hybrid Quantum-Classical Spike-Driven Network for MRI-Based Alzheimer's Stage Prediction.
    Int J Neurosci. 2026 Jun 4:1-30. doi: 10.1080/00207454.2026.2683880.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

19. DENG J, Li S
    Association of Alzheimer's disease blood-based biomarkers and visit-to-visit blood pressure variability: The HABS-HD study.
    J Alzheimers Dis. 2026 Jun 4:13872877261457455. doi: 10.1177/13872877261457455.
    PubMed         Abstract available
    
    
20. GOTZE K, Auboeuf-Dominguez F, Akroum M, Bellosta CT, et al
    Anti-amyloid immunotherapies in Alzheimer's disease: Are future prescribers prepared? Insights of a French national survey.
    J Alzheimers Dis. 2026 Jun 4:13872877261452180. doi: 10.1177/13872877261452180.
    PubMed         Abstract available
    
    
21. TSUTSUI S, Stepanchuk AA, Stys JP, Black SAG, et al
    Fluorescence spectroscopy and machine learning methods for detection of Alzheimer's disease from circulating white blood cells.
    J Alzheimers Dis. 2026 Jun 3:13872877261453512. doi: 10.1177/13872877261453512.
    PubMed         Abstract available
    
    
22. ALCALA RAMIREZ DEL PUERTO JM, Ortega-Madueno I, Gil-Moreno MJ, Abizanda-Saro P, et al
    Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical practice.
    J Alzheimers Dis. 2026;111:979-984.
    PubMed         Abstract available
    
    
23. MUSAEUS CS, Curnin CB, Muthupalaniappan S, Friedman G, et al
    Feasibility and validity of the D-Cog: A novel digital spatial working memory test for dementia assessment.
    J Alzheimers Dis. 2026;111:1309-1316.
    PubMed         Abstract available
    
    
24. STIMMELL AC, Alday LJ, Salvador EM, Marquez Diaz J, et al
    Resting after learning facilitates memory consolidation and reverses spatial reorientation impairments in female 3xTg-AD mice.
    J Alzheimers Dis. 2026;111:991-1013.
    PubMed         Abstract available
    
    
25. TAHA MME, Abdelwahab SI, Sahli KA, Jeraiby M, et al
    A century of coffee and tea research in cognitive health and Alzheimer's disease: Structural, thematic, and translational insights (1911-2025).
    J Alzheimers Dis. 2026 May 30:13872877261450996. doi: 10.1177/13872877261450996.
    PubMed         Abstract available
    
    
26. WEN T, Zhu T, Zhou LY, Ran Z, et al
    Bibliometric analysis of natural medicine in the treatment of Alzheimer's disease: Trends, hotspots, and emerging research fields.
    J Alzheimers Dis. 2026 May 30:13872877261451887. doi: 10.1177/13872877261451887.
    PubMed         Abstract available
    
    
27. DOS SANTOS SILVA J
    Cannabinoids for Alzheimer's disease: A promising trial, although not yet ready for the prescription pad.
    J Alzheimers Dis. 2026 May 30:13872877261452183. doi: 10.1177/13872877261452183.
    PubMed         Abstract available
    
    
28. ZHAO Y, Liu C, Yv K, Wang N, et al
    Integrative genomic and transcriptomic analysis identifies microglia-expressed genes with causal links to Alzheimer's disease risk.
    J Alzheimers Dis. 2026 Jun 2:13872877261452242. doi: 10.1177/13872877261452242.
    PubMed         Abstract available
    
    
29. SAINZ-PARDO M, Hernandez M, Suades A, Juncadella M, et al
    Naming performance in bilinguals with Alzheimer's disease and mild cognitive impairment.
    J Alzheimers Dis. 2026 Jun 2:13872877261452694. doi: 10.1177/13872877261452694.
    PubMed         Abstract available
    
    
30. LI J, Lian T, Guo P, Li J, et al
    Gut-brain axis crosstalk in patients with Alzheimer's disease and high body mass index: Gut dysbiosis, blood-brain barrier disruption, and neuroinflammation.
    J Alzheimers Dis. 2026 Jun 2:13872877261441465. doi: 10.1177/13872877261441465.
    PubMed         Abstract available
    
    
31. CHEN Y, Huang H, He Y, Chen S, et al
    Speech-based machine learning for detecting neuropsychiatric symptoms in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jun 2:13872877261456293. doi: 10.1177/13872877261456293.
    PubMed         Abstract available
    
    
32. ZHANG J, Teng Y, Li Y, Zhang M, et al
    Global research landscape of oligodendrocytes in Alzheimer's disease: A bibliometric and knowledge-mapping analysis from 1990 to 2025.
    J Alzheimers Dis. 2026 Jun 2:13872877261456313. doi: 10.1177/13872877261456313.
    PubMed         Abstract available
    
    
33. WIECHMANN D, Gunes A, Kerz E, Qiao Y, et al
    Connected-speech digital biomarkers for monitoring transcranial pulse stimulation in Alzheimer's disease: A pilot study.
    J Alzheimers Dis. 2026 Jun 3:13872877261456294. doi: 10.1177/13872877261456294.
    PubMed         Abstract available
    
    
34. CHEN M, Xie Q, Yi F, Ma J, et al
    Secoisolariciresinol diglucoside ameliorates Alzheimer-like lesions by increasing MKP-1.
    J Alzheimers Dis. 2026 Jun 3:13872877261450557. doi: 10.1177/13872877261450557.
    PubMed         Abstract available
    
    

    
    J Neurol

35. IHARA Y, Miyaue N, Ihara M, Kurata T, et al
    Association of probiotic medication use with incident Parkinson disease and alzheimer disease: a nationwide nested case-control study.
    J Neurol. 2026;273:349.
    PubMed         Abstract available
    
    

    
    Neurochem Res

36. OZKURT C, Kose S, Karasu C, Kortholt A, et al
    Taliglucerase Alfa Reduces Amyloid-beta Burden by Restoring Autophagic Pathways in a Neuronal Model of Alzheimer's Disease.
    Neurochem Res. 2026;51:181.
    PubMed         Abstract available
    
    

    
    Neurology

37. TRIEU C, Dicks E, de Leeuw D, de Wit KDM, et al
    Longitudinal Change in Blood-Based Biomarkers and the Association With MRI-Measured Neurodegeneration in Cognitively Unimpaired Individuals.
    Neurology. 2026;106:e218119.
    PubMed         Abstract available
    
    
38. KIM D, McInerney K, Dagli C, Armstrong ND, et al
    Influence of Cardiometabolic and Alzheimer Disease Genetics on Cognitive-Related Outcomes in a Diverse Population.
    Neurology. 2026;107:e218163.
    PubMed         Abstract available
    
    

    
    PLoS One

39. MORRIS C, Mok PLH, Robinson DL, Allan L, et al
    Prescribing of anti-dementia medications in primary care: A retrospective cohort study in 1489 English General Practices.
    PLoS One. 2026;21:e0347921.
    PubMed         Abstract available
    
    
40. VALDEVILA FIGUEIRA JA, Monteros Andrade MAEL, Yambay-Bautista XR, Ramirez A, et al
    Knowledge about Alzheimer's disease in medical, nursing, and psychology students in Ecuador: A problem that needs an urgent solution.
    PLoS One. 2026;21:e0350624.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum